Wednesday, November 15, 2017

US FDA News: FDA grants marketing authorization of the first device for use in helping to reduce the symptoms of opioid withdrawal

FDA permits marketing of the first device for use in helping to reduce the symptoms of opioid withdrawal
Read more: FDA grants marketing authorization of the first device for use in helping to reduce the symptoms of opioid withdrawal